• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about psilocybin therapy

Recent news which mentions psilocybin therapy

Kaya Holdings Advocates For Psilocybin As FDA Rejects MDMA For PTSD Treatment
August 14, 2024
Tickers KAYS NEWS
Tags Regulations Kaya Holdings News
From Benzinga
Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions
March 25, 2024
Tickers NEWS NUMIF
Tags Psychedelics psilocybin therapy FDA
From Benzinga
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
March 04, 2024
Tickers ATAI CMND CMPS CYBN
Tags Cannabis ATAI Psychedelics Research
From Benzinga
Washington Doctor Vs. DEA For Lawful Use Of Psilocybin To Treat Terminally Ill Patients
February 14, 2024
Tickers NEWS
Tags News Cannabis right/to/try laws
From Benzinga
Canadian At-Home Microdose Psilocybin Clinical Trial Finalized, Here Are The Details
March 31, 2023
Tags News Cannabis Psilocybin Microdosing
From Benzinga
Meth Use Disorder Tackled With Psilocybin: Clinical Trial Begins Patient Enrollment
March 28, 2023
Tickers RVVTF
Tags Psychedelic/Assisted Therapies Market News Penny Stocks
From Benzinga
Canada's Ongoing Struggle For Access To Natural Psilocybin As A Therapeutic Nabs Business Support
February 15, 2023
Tickers TRUFF
Tags Psychedelics psilocybin therapy Guidance
From Benzinga
Canadian Psychedelics Company Launches Take-Home Psilocybin Trial For Some 300 Participants
February 01, 2023
Tags Psychedelic/Assisted Therapies Global Apex Labs
From Benzinga
Virginia Psychedelics: Legalizing Medical Use Of Psilocybin Gets A Thumbs Down
January 20, 2023
Tags Markets News Cannabis
From Benzinga
2023 Could Be Make Or Break For Psychedelics In Missouri, This GOP Lawmaker Is Pushing For Change
January 09, 2023
Tags Cannabis News Market News
From Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
January 03, 2023
Tickers ATAI AWKNF CMND CMPS
Tags Small Cap Cannabis ATAI
From Benzinga
Oregon's Final Rules For Psilocybin Services Are Ready, Learn What To Expect
December 28, 2022
Tags Oregon Health Authority Cannabis Market News
From Benzinga
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
December 27, 2022
Tickers KONEF NMLSF
Tags Psychedelics psilocybin therapy Markets
From Benzinga
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries
December 21, 2022
Tags News Cannabis Health Canada Special Access Program
From Benzinga
Potential Road To At-Home Psychedelics Use Permits: Low Dosing's Positive Outcomes In Phase 1 Trial
December 12, 2022
Tags News Cannabis Diamond Therapeutics Inc/
From Benzinga
Magic Mushrooms Tested For Treating Type II Bipolar Disorder, Check Out Results So Far
December 12, 2022
Tickers CMPS
Tags Small Cap Cannabis bipolar disorder
From Benzinga
DEA's Consistent Denial Of Psilocybin Access For Terminally Ill Being Challenged Again
October 27, 2022
Tickers CSA DEA
Tags psilocybin therapy Psychedelics Markets
From Benzinga
In Oregon You Can Get Trained To Be A Licensed Psilocybin Therapy Provider
October 07, 2022
Tags Measure 109 Market News Fluence
From Benzinga
Cannabis & Psychedelics As Effective Adjunct Medicine To Breast Cancer Therapy? Studies Say Yes
September 30, 2022
Tags Benzinga Breast Cancer Therapy Psychedelics
From Benzinga
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: What Science Is Saying
September 22, 2022
Tickers CMPS
Tags CMPS alcohol addiction News
From Benzinga
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: The Legal Situation
September 19, 2022
Tags Psychedelics psilocybin therapy Benzinga
From Benzinga
Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction
September 16, 2022
Tickers RVVTF
Tags Dr/ Paul Hutson Benzinga Psychedelics
From Benzinga
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
September 14, 2022
Tickers MSSTF
Tags News MSSTF Clerkenwell Health
From Benzinga
Psychedelics Companies Are Teaming Up To Offer Access Veterans
September 13, 2022
Tickers AWKNF RVLWF
Tags News RVLWF Penny Stocks
From Benzinga
Cathie Wood's Psychedelics Fund ARK Analyzes The Sector's Present & Future And Likes What It Sees
September 06, 2022
Tickers ATAI
Tags Market News Cannabis ATAI
From Benzinga
Study Finds Psilocybin Anti-Depression Effects Last At Least One Year
March 04, 2022
Tags Market News John Hopkins University Cannabis
From Benzinga
The Case For Psilocybin Therapy And Depression
January 30, 2022
Tags Market News Cannabis contributors
From Benzinga
ATAI Life Sciences Announces New Program To Discover Next-Generation Mental Health Treatments
January 27, 2022
Tickers ATAI
Tags Penny Stocks mental health General
From Benzinga
Psilocybin Therapy Combined With SSRI Antidepressants Is Possible, COMPASS Study Confirms
December 13, 2021
Tickers CMPS
Tags Markets News CMPS
From Benzinga
Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake In Compass Pathways
November 29, 2021
Tickers ATAI CMPS
Tags Government Benzinga psilocybin therapy
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap